FOYA Program

iSpeak Blog

Winners in this category exemplify the application of novel tools and approaches to delivering projects that improved efficiencies, overcame unusual challenges, promoted effectiveness, and organized stakeholders and project team participants in ways that led to successful outcomes such as efficiency, delivery, quality, product yield, consistency, and cost of goods.

iSpeak Blog

FOYA Winners in the Supply Chain Category exemplify the novel application of process manufacturing techniques, innovative design concepts, new technologies, and unique solutions that exemplify the next generation of agile, flexible, efficient, and effective new and existing pharmaceutical and biotechnology facilities. This includes implementation of commercially available and custom developed...

iSpeak Blog

Pharma 4.0™ is a new category for the Facility of the Year Awards (FOYA) program. Winners in the Pharma 4.0 category embody the Pharma 4.0 concept. This includes not only implementing at least one technological innovation, but also demonstrating the ability to change the company’s culture, processes, and people orienting them towards a 4.0 future. Significant contributions include application...

Features

What do recipients of ISPE’s prestigious Facilities of the Year Award (FOYA) know that has helped their projects succeed? What are the lessons learned from achievements in facilities development, including forward-looking projects that encompass and inspire changes in the industry? Pharmaceutical Engineering® spoke with nine FOYA winners from recent years about the lessons they learned and...

Media & Press Releases
26 April 2022
ISPE today announced the 2022 Facility of the Year Awards (FOYA) Category Winners at the 2022 ISPE Europe Annual Conference in Madrid, Spain.  Category Winners Include:  CRISPR Therapeutics ( Innovation) Janssen Biologics, BV ( Project Execution) ...
Given the unique challenges surrounding the COVID – 19 Pandemic, there are two projects the judges are recognizing in the category of Social Impact. Under normal circumstances, projects of this type are challenging...
Iovance Biotherapeutics, Inc. Location: Philadelphia, Pennsylvania, USA Project: Iovance Cell Therapy Center (iCTC) 136,000-square-foot, three-story, greenfield facility houses manufacturing, central utilities...
Given the unique challenges surrounding the COVID – 19 Pandemic, there are two projects the judges are recognizing in the category of Social Impact. Under normal circumstances, projects of this type are challenging...
Takeda Pharmaceuticals International AG Location: Singen, Germany Project: TaSiVa Takeda Pharmaceuticals International AG is a global, patient-centric, and science-driven biopharmaceutical company with headquarters in...